Prenetics Global Limited (PRE) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PRE SEC filings page.
Prenetics Global Limited (PRE) reported $92.4M in revenue for fiscal year 2025, up 201.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue has scaled sharply, but the business still relies on financing because operating cash flow remains negative despite narrowing losses.
From FY2022 to FY2025, the net margin improved from-14.5% to-0.4% , yet operating cash flow moved from positive to negative. In FY2025, the net loss was$40.0M while operating cash flow was-$21.8M , showing that accounting losses exceeded the cash outflow rather than translating cleanly into cash generation.
Revenue reached
The balance sheet is lightly debt-funded, with a current ratio of 3.0x and debt-to-equity of 0.003x, but FY2025 financing cash flow of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Prenetics Global Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Prenetics Global Limited held $32.1M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $21.8M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Prenetics Global Limited scores 42/100 among other emerging companies.
Prenetics Global Limited had 17M shares outstanding at the end of fiscal year 2025, against 13M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Prenetics Global Limited scores 38/100 among other emerging companies.
Not available for Prenetics Global Limited, and counted as zero in the overall score.
Prenetics Global Limited reported revenue of $92.4M in fiscal year 2025, against $30.6M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Prenetics Global Limited scores 87/100 among other emerging companies.
Prenetics Global Limited's operations used $21.8M of cash in fiscal year 2025, against $28.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Prenetics Global Limited scores 26/100 among other emerging companies.
Prenetics Global Limited's cash, cash equivalents and investments came to $32.1M at the end of fiscal year 2025, against $49.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Prenetics Global Limited scores 48/100 among other emerging companies.
Prenetics Global Limited passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Prenetics Global Limited reported a net loss of $40.0M while operations used $21.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q3 2025.
Cash & Balance Sheet
Prenetics Global Limited held $52.3M in cash against $3.0M in long-term debt as of Q3 2025.
Not reported for Q3 2025.
Not reported for Q3 2025.
Margins & Returns
None of these metrics is reported for Q3 2025.
Capital Allocation
None of these metrics is reported for Q3 2025.
PRE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
PRE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-K | Q3'2410-K | Q3'2310-K | Q3'2210-K |
|---|---|---|---|---|
| Total Assets | $213.6M-16.0% | $254.2M-18.6% | $312.1M+110.2% | $148.5M |
| Current Assets | $86.1M-8.0% | $93.7M-61.3% | $241.8M+126.2% | $106.9M |
| Cash & Equivalents | $52.3M+14.3% | $45.7M-68.8% | $146.7M+315.6% | $35.3M |
| Inventory | $6.6M+110.0% | $3.1M-31.0% | $4.5M-33.6% | $6.8M |
| Accounts Receivable | $16.8M-5.0% | $17.7M-66.8% | $53.2M-3.1% | $54.9M |
| Goodwill | $37.4M+28.1% | $29.2M-13.7% | $33.8M+749.7% | $4.0M |
| Total Liabilities | $42.2M-4.1% | $44.0M-35.9% | $68.7M-87.5% | $549.4M |
| Current Liabilities | $36.6M-7.4% | $39.5M-31.0% | $57.2M-2.6% | $58.7M |
| Non-Current Liabilities | $5.7M+25.4% | $4.5M-60.5% | $11.5M-97.7% | $490.7M |
| Long-Term Debt | $3.0M+247.6% | $867K-77.0% | $3.8M+4.5% | $3.6M |
| Total Equity | $171.3M-18.5% | $210.2M-13.7% | $243.5M+160.7% | -$400.9M |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Retained Earnings.
PRE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
PRE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Prenetics Global Limited PRE | FY2025 | $92.4M | -$40.0M | -43.3% | $351.7M | 40/100 |
| Burning Rock Biotech Limited BNR | FY2025 | $77.2M | -$7.9M | -10.3% | $171.4M | 60/100 |
| Fonar Corporation FONR | FY2025 | $104.4M | $8.3M | 8.0% | $120.2M | 63/100 |
| MDxHealth SA MDXH | FY2025 | $107.9M | -$33.5M | -31.1% | $54.5M | 29/100 |
| Exagen Inc. XGN | FY2025 | $66.6M | -$20.0M | -30.0% | $197.9M | 47/100 |
| Biodesix, Inc. BDSX | FY2025 | $88.5M | -$35.3M | -39.9% | $292.5M | 51/100 |
Where Prenetics Global Limited Ranks
Frequently Asked Questions
What is Prenetics Global Limited's annual revenue?
Prenetics Global Limited (PRE) reported $92.4M in total revenue for fiscal year 2025. This represents a 201.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Prenetics Global Limited's revenue growing?
Prenetics Global Limited (PRE) revenue grew by 201.7% year-over-year, from $30.6M to $92.4M in fiscal year 2025.
Is Prenetics Global Limited profitable?
No, Prenetics Global Limited (PRE) reported a net income of -$40.0M in fiscal year 2025, with a net profit margin of -43.3%.
How much debt does Prenetics Global Limited have?
As of fiscal year 2025, Prenetics Global Limited (PRE) had $32.1M in cash and equivalents against $437K in long-term debt.
What is Prenetics Global Limited's net profit margin?
Prenetics Global Limited (PRE) had a net profit margin of -43.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Prenetics Global Limited's return on equity (ROE)?
Prenetics Global Limited (PRE) has a return on equity of -25.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Prenetics Global Limited's free cash flow?
Prenetics Global Limited (PRE) recorded an outflow of $22.0M in free cash flow during fiscal year 2025. This represents a 26.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Prenetics Global Limited's operating cash flow?
Prenetics Global Limited (PRE) recorded an outflow of $21.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Prenetics Global Limited's total assets?
Prenetics Global Limited (PRE) had $206.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Prenetics Global Limited's capital expenditures?
Prenetics Global Limited (PRE) invested $208K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Prenetics Global Limited's current ratio?
Prenetics Global Limited (PRE) had a current ratio of 2.97 as of fiscal year 2025, which is generally considered healthy.
What is Prenetics Global Limited's debt-to-equity ratio?
Prenetics Global Limited (PRE) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Prenetics Global Limited's return on assets (ROA)?
Prenetics Global Limited (PRE) had a return on assets of -19.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Prenetics Global Limited's P/E ratio?
Prenetics Global Limited (PRE) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $351.7M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Prenetics Global Limited's price-to-sales ratio?
Prenetics Global Limited (PRE) trades at 3.8x sales, its market capitalization divided by revenue of $92.4M revenue, FY2025. The market capitalization is $351.7M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Prenetics Global Limited's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Prenetics Global Limited (PRE) held $32.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $21.8M over that year. Dividing the one by the other, the reported balance equals about 18 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Prenetics Global Limited's Piotroski F-Score?
Prenetics Global Limited (PRE) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Prenetics Global Limited's earnings high quality?
Prenetics Global Limited (PRE) reported a net loss of $40.0M while operations used $21.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Prenetics Global Limited?
Prenetics Global Limited (PRE) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.